Iberia Pharmaceuticals Launches KeyCi Skincare Line to Cater to Indian Consumers

New Delhi — Iberia Pharmaceuticals, an established player in the pharmaceutical sector, has introduced KeyCi, a skincare brand developed through rigorous scientific research and clinical testing. The launch has generated substantial consumer enthusiasm across the country, signalling growing demand for evidence-based skincare solutions that combine efficacy with sustainability and inclusivity.

Since its market entry, KeyCi has attracted thousands of consumers seeking affordable luxury products without compromising on quality. The brand bridges the gap between everyday skincare routines and clinical-grade formulations, with offerings specifically calibrated for Indian skin types and environmental conditions.

The KeyCi portfolio comprises four core products: Barrier Repair Ultra Hydrating Facial Cleanser, Skin Brightening Face Serum, Barrier Repair Ultra Hydrating Skin Moisturizer, and InvisiBlock Advanced Fluid Sunscreen SPF 50 PA ++++. All formulations are vegan, cruelty-free, alcohol-free, paraben-free, and FDA approved. Designed to appeal to consumers between 18 and 45 years old, the products are gender-neutral and suitable across all skin types.

The brand's formulations incorporate liposomal delivery systems, enabling deeper skin penetration, sustained ingredient release, and enhanced bioavailability. Each product has undergone dermatological testing and is supported by pharma-grade research and development protocols.

KeyCi's development spanned several years, with Iberia's internal research team collaborating with dermatologists and clinical partners to ensure safety, efficacy, and local relevance. The company prioritised formulations grounded in dermatological science while accounting for India's climate and lifestyle patterns.

"Our goal is to establish ourselves as a global leader in clean beauty and redefine skincare standards," said Nitin Jain, Founder and Managing Director of Iberia Pharmaceuticals. "The overwhelming response to our initial rollout has validated consumer confidence in scientifically-formulated skincare. We have concentrated on creating formulations anchored in dermatological expertise and pharmaceutical rigour, adapted specifically to Indian environmental and lifestyle conditions."

Saurav Ojha, Co-Founder and Whole-Time Director, added: "KeyCi represents our commitment to merging clinical research, safe formulations, and responsible manufacturing. The strong early market reception has reinforced the need for skincare products that combine scientific formulation with environmental consciousness. We are planning to introduce additional items to the KeyCi range in the coming months."

Iberia Pharmaceuticals has built its reputation through multiple established brands including Sesderma, Mediderma, Dermpix, Metacare, and Noreva. Operating for more than several decades, the company has become a trusted supplier of pharmaceutical products to Indian and global markets. The company leverages nanotechnology in its formulations to deliver active ingredients with precision and heightened effectiveness. What began as a singular concept has evolved into a comprehensive operation featuring state-of-the-art manufacturing infrastructure, dedicated research and development facilities, and countrywide distribution networks.